Full-Time

Senior Software Quality Engineer

Posted on 8/14/2025

Neptune Medical

Neptune Medical

1-10 employees

At-home fertility diagnostics and non-invasive device

Compensation Overview

$140k - $175k/yr

+ Equity + 401(k) Match

Burlingame, CA, USA

In Person

Category
QA & Testing (1)
Required Skills
Risk Management
Requirements
  • Bachelor's degree in Computer Science, Software Engineering, or a related field.
  • Minimum of 5 years of experience in software quality assurance, preferably in the medical device industry.
  • Strong understanding of IEC 62304, ISO 14971, and other relevant standards and regulations governing medical device software.
  • Experience with software verification and validation methodologies, including test planning, execution, and reporting.
  • Proficiency in risk management techniques and tools, with experience in conducting risk assessments.
  • Excellent communication and collaboration skills, with the ability to work effectively in cross-functional teams.
  • Attention to detail and strong analytical skills, with the ability to troubleshoot and solve complex problems.
Responsibilities
  • Work closely with the product development team to develop software requirements and manage the quality of software used in a complex electromechanical robotic system.
  • Develop and implement software quality plans, procedures, and policies to ensure adherence to quality standards.
  • Conduct internal audits and assessments to identify areas for improvement and ensure compliance with quality management systems related to software quality.
  • Provide corrective and preventive actions (CAPA) and audit support in the area of software quality.
  • Plan, execute, and oversee software verification and validation activities, including test strategy development, test case creation, and test execution for product software and non-product software.
  • Analyze test results and provide recommendations for corrective actions to ensure software meets specified requirements and quality standards.
  • Participate in risk management activities related to software development, including hazard analysis, risk assessment, and risk mitigation planning per ISO 14971.
  • Collaborate with cross-functional teams to identify and address software-related risks throughout the product lifecycle.
  • Prepare and maintain documentation related to software quality activities, including test plans, test reports, and compliance documentation.
  • Generate periodic reports on software quality metrics, trends, and compliance status for management review.
  • Ensure compliance with relevant regulations and standards, particularly IEC 62304, throughout the software development lifecycle.
  • Review and interpret regulatory requirements related to software quality and provide guidance to the development team.
  • Monitor industry trends, best practices, and regulatory updates related to software quality assurance and incorporate them into existing processes.
  • Drive continuous improvement initiatives to enhance software development processes and increase efficiency and effectiveness.
Desired Qualifications
  • Advanced degree in Computer Science, Software Engineering, or a related field
  • Prior experience in and understanding of systems engineering and robotic controls
  • Cybersecurity experience
  • Experience with medical device non-product software validation
  • Small company or startup experience
  • Experience with disposables/consumables
  • Experience working with contract manufacturers
  • Experience working on roboticized surgical systems
  • Certification in software quality assurance or related areas (e.g., ASQ Certified Software Quality Engineer)

Neptune Medical develops devices and tests to address male infertility. Its two main products are Pro-Test, an at-home diagnostic kit that lets individuals test fertility parameters from home, and Neptune, a non-invasive device designed to improve sperm quality. Pro-Test provides a convenient way to assess fertility without clinic visits, while Neptune uses a proprietary, non-invasive method to enhance key sperm metrics and is intended for home use alongside clinical fertility treatment. The company serves both clinics (B2B) and individual consumers (B2C) and markets its products to help diagnose and treat male infertility, a factor in about half of all infertility cases. Neptune Medical differentiates itself by offering integrated, consumer-accessible diagnostics and treatment tools, backed by grant funding and participation in precision medicine programs, aiming to make diagnosis and treatment more private, accessible, and effective.

Company Size

1-10

Company Stage

Series D

Total Funding

$97M

Headquarters

Burlingame, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Varicocele embolization boosts sperm parameters, complementing Neptune's enhancement device.
  • E-cigarette harm awareness drives Pro-Test demand for lifestyle-impacted diagnostics.
  • Innovate UK and Horizon 2020 grants validate clinical innovation for market entry.

What critics are saying

  • Varicocele embolization by University Radiology eliminates Neptune device need in 12-24 months.
  • RSC New Jersey clinics integrate evaluations, cutting Pro-Test demand in 6-18 months.
  • Clomiphene citrate adoption by urologists cannibalizes device market in 12-24 months.

What makes Neptune Medical unique

  • Pro-Test delivers at-home male fertility diagnostics for convenient sperm analysis.
  • Neptune device non-invasively enhances sperm quality via patented home-use technology.
  • Targets male infertility gap, serving B2B clinics and B2C consumers since 2018.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Company Equity

Company News

The Robot Report
Oct 4th, 2024
Robotics Investments Near $1B In August

Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies

Business Wire
Aug 17th, 2024
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.

INACTIVE